FR2741072B1 - Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique - Google Patents

Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique

Info

Publication number
FR2741072B1
FR2741072B1 FR9513257A FR9513257A FR2741072B1 FR 2741072 B1 FR2741072 B1 FR 2741072B1 FR 9513257 A FR9513257 A FR 9513257A FR 9513257 A FR9513257 A FR 9513257A FR 2741072 B1 FR2741072 B1 FR 2741072B1
Authority
FR
France
Prior art keywords
oxazolidin
derivatives
preparation
therapeutic application
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9513257A
Other languages
English (en)
Other versions
FR2741072A1 (fr
Inventor
Samir Jegham
Frederic Puech
Philippe Burnier
Danielle Berthon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9513257A priority Critical patent/FR2741072B1/fr
Priority to PCT/FR1996/001732 priority patent/WO1997017347A1/fr
Priority to US09/066,364 priority patent/US5925662A/en
Priority to JP9517919A priority patent/JP2000500127A/ja
Priority to EP96937392A priority patent/EP0859776A1/fr
Publication of FR2741072A1 publication Critical patent/FR2741072A1/fr
Application granted granted Critical
Publication of FR2741072B1 publication Critical patent/FR2741072B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9513257A 1995-11-09 1995-11-09 Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique Expired - Fee Related FR2741072B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9513257A FR2741072B1 (fr) 1995-11-09 1995-11-09 Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
PCT/FR1996/001732 WO1997017347A1 (fr) 1995-11-09 1996-11-05 Composes derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
US09/066,364 US5925662A (en) 1995-11-09 1996-11-05 Compounds derived from oxazolidin-2-one and preparation and therapeutical use thereof
JP9517919A JP2000500127A (ja) 1995-11-09 1996-11-05 オキサゾリジン−２−オン誘導化合物、その製造方法および医薬への用途
EP96937392A EP0859776A1 (fr) 1995-11-09 1996-11-05 Composes derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9513257A FR2741072B1 (fr) 1995-11-09 1995-11-09 Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2741072A1 FR2741072A1 (fr) 1997-05-16
FR2741072B1 true FR2741072B1 (fr) 1997-12-12

Family

ID=9484384

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9513257A Expired - Fee Related FR2741072B1 (fr) 1995-11-09 1995-11-09 Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique

Country Status (5)

Country Link
US (1) US5925662A (fr)
EP (1) EP0859776A1 (fr)
JP (1) JP2000500127A (fr)
FR (1) FR2741072B1 (fr)
WO (1) WO1997017347A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3865450B2 (ja) * 1997-02-14 2007-01-10 田辺製薬株式会社 パーキンソニズム治療剤
HUP0401858A3 (en) * 2001-01-31 2009-06-29 Lundbeck & Co As H Gal3 receptor antagonist pyrimidine and indolone-derivatives and their use for preparation of pharmaceutical compositions suitable for the treatment of depression and/or anxiety
KR100760072B1 (ko) * 2001-12-04 2007-09-18 에프. 호프만-라 로슈 아게 고리 축합된 피라졸 유도체
CN101193892A (zh) 2005-06-14 2008-06-04 先灵公司 大环杂环天冬氨酰基蛋白酶抑制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006524A1 (fr) * 1978-06-22 1980-01-09 Ciba-Geigy Ag Dérivés de tétrahydropyridine et de tétrahydropipéridine, leurs sels d'addition acides, procédés pour leur préparation et compositions pharmaceutiques les contenant
CA1171865A (fr) * 1980-06-04 1984-07-31 Alain Lacour Derives de n-aryl-azolone, methode de preparation et utilisation a des fins therapeutiques
US5235063A (en) * 1989-10-17 1993-08-10 Delalande S.A. Process of preparing by condensation certain
US5196543A (en) * 1989-10-17 1993-03-23 Delalande S.A. 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
FR2653017B1 (fr) * 1989-10-17 1995-05-05 Delalande Sa Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
JPH08151577A (ja) * 1994-11-30 1996-06-11 Canon Inc 光学活性化合物、それを含有する液晶組成物、それを有する液晶素子、それらを用いた液晶装置及び表示方法

Also Published As

Publication number Publication date
JP2000500127A (ja) 2000-01-11
FR2741072A1 (fr) 1997-05-16
EP0859776A1 (fr) 1998-08-26
US5925662A (en) 1999-07-20
WO1997017347A1 (fr) 1997-05-15

Similar Documents

Publication Publication Date Title
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
FR2667317B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2681325B1 (fr) Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2735475B1 (fr) Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2753970B1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2741072B1 (fr) Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2638747B1 (fr) Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2672601B1 (fr) Derives de benzo-1,5-thiazepine, leur preparation et leur application en therapeutique.
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2753196B1 (fr) Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2769914B1 (fr) Derives d'indazole tricycliques leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
FR2731707B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2738567B1 (fr) Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique
FR2724383B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse
ST Notification of lapse